Events and Presentations Events and Presentations Upcoming Events There are no upcoming events available at this time. Past Events May 12, 2020 Stoke Therapeutics at American Society of Gene and Cell Therapy Annual Meeting Supporting Materials Poster: Antisense oligonucleotide mediated increase of OPA1 expression using TANGO technology for treatment of autosomal dominant optic atrophy 991.2 KB March 2, 2020 at 3:30 PM EST Stoke Therapeutics at Cowen 40th Annual Health Care Conference Location Boston, MA Click here for webcast Presentations Corporate Presentation – May 2020 Poster: Antisense oligonucleotide mediated increase of OPA1 expression using TANGO technology for treatment of autosomal dominant optic atrophy Toolkit Print Page Email Alerts Contact IR FAQ
Events and Presentations Upcoming Events There are no upcoming events available at this time. Past Events May 12, 2020 Stoke Therapeutics at American Society of Gene and Cell Therapy Annual Meeting Supporting Materials Poster: Antisense oligonucleotide mediated increase of OPA1 expression using TANGO technology for treatment of autosomal dominant optic atrophy 991.2 KB March 2, 2020 at 3:30 PM EST Stoke Therapeutics at Cowen 40th Annual Health Care Conference Location Boston, MA Click here for webcast Presentations Corporate Presentation – May 2020 Poster: Antisense oligonucleotide mediated increase of OPA1 expression using TANGO technology for treatment of autosomal dominant optic atrophy
May 12, 2020 Stoke Therapeutics at American Society of Gene and Cell Therapy Annual Meeting Supporting Materials Poster: Antisense oligonucleotide mediated increase of OPA1 expression using TANGO technology for treatment of autosomal dominant optic atrophy 991.2 KB
Poster: Antisense oligonucleotide mediated increase of OPA1 expression using TANGO technology for treatment of autosomal dominant optic atrophy 991.2 KB
March 2, 2020 at 3:30 PM EST Stoke Therapeutics at Cowen 40th Annual Health Care Conference Location Boston, MA Click here for webcast
Poster: Antisense oligonucleotide mediated increase of OPA1 expression using TANGO technology for treatment of autosomal dominant optic atrophy